Pharmaceutical Technology

JUNE 19, 2023

Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. Laurus Labs will be responsible for launching these products in India and emerging markets.

Gene Therapy 246

Gene Therapy Gene Production Pharma Companies 246

pharmaphorum

AUGUST 1, 2024

Valneva has bolstered its vaccines pipeline with a shot designed to protect against shigellosis – a major global health threat – licensed from LimmaTech Biologics.The French pharma company – best known for its COVID-19 jab and recent approval for the world's first chikungunya vaccine Ixchiq – is paying €10 million upfront for a stake in LimmaTech's (..)

Vaccination 105

Vaccination Vaccine Pharma Companies Licensing 105

Fossil Remedies

OCTOBER 16, 2022

When you launch a PCD pharma company , you have to do several preparations. In a pharma business, you have a distribution network like a pharma manufacturing company, pharma marketing company, C&F agents, wholesalers/distributors/stockiest, retailers, and pharmacies. Wholesale Drug License.

Licensing 52

Licensing Licensing Pharma Companies Manufacturing 52

pharmaphorum

APRIL 22, 2021

Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. The pharma company will use the technology known as accelerateIQ to collect data across its clinical studies through a variety of wearable biosensors.

Licensing 72

Licensing Licensing Trials Clinical Trials 72

BioSpace

MARCH 17, 2021

Multiple pharmaceutical companies struck large licensing deals with one another this week. Here's a look.

Pharma Companies 57

Pharma Companies Licensing Licensing 57

Outsourcing Pharma

MARCH 2, 2023

A licensing agreement has been signed that will give Spanish pharma company, Ferrer, worldwide rights to a treatment for progressive supranuclear palsy (PSP).

Licensing 52

Licensing Licensing Pharma Companies Development 52

pharmaphorum

JANUARY 29, 2021

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to $410 million. The post Lilly adds to pain pipeline with Asahi Kasei licensing deal appeared first on.

Licensing 52

Licensing Licensing Bioavailability Antibody 52

Camargo

NOVEMBER 11, 2020

Unpacking the (Black) Box: Antares Licenses Urology Product with Boxed Warning. In October, Antares Pharma licensed Ferring Pharmaceuticals’ Nocdurna® (desmopressin acetate) sublingual tablet , which was approved in 2018 for the same indication as Noctiva and has a boxed warning highlighting the same risks.

Development 242

Development Bioequivalency Generic Drugs Production 242

Fossil Remedies

JANUARY 19, 2022

Experts say that one should choose an ISO-certified company that works as per the standards and guidelines laid by WHO and GMP. The company should have a countrywide distribution network and a customer-oriented approach. The PCD pharma company you choose should have a good reputation and bright history.

Production 98

Production Pharma Companies Pharma Production Marketing 98

pharmaphorum

FEBRUARY 3, 2022

India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an undisclosed sum.

Licensing 119

Licensing Licensing Marketing Medicine 119

pharmaphorum

MAY 4, 2022

Once selected, Quris can in-license them, progress them through to phase 1 trials and, those that succeed, can be licensed to pharma companies. In this manner, Bentwich explained that Quris is able to profit from the higher rates that are paid for post-phase 1 drug candidates, with the value typically tripling.

Drugs 143

Drugs Licensing Licensing Pharma Companies 143

Pharmaceutical Technology

APRIL 17, 2023

Telix has announced the successful preclinical development of radiolabelled olaratumab, an antibody licensed by Eli Lilly and Company. If the Australian pharma company can demonstrate a renewed potential for the drug, Lilly could receive up to $255m in commercial and regulatory milestone payments.

Development 130

Development Antibody Pharma Companies Licensing 130

Pharmaceutical Technology

AUGUST 1, 2022

As a result, multiple vaccines, including Pfizer /BioNTech’s mRNA vaccine, Comirnaty, were licensed for use within a year of development beginning. If robust support comes from governments, pharma companies will grow in confidence about entering this area, and hopefully, a much-needed flurry of antibiotics will be developed.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

World of DTC Marketing

APRIL 12, 2021

A blood-thinning agent, heparin, had been adulterated due to the product license holder (Baxter) procuring a toxic substance that had been illegally substituted for the genuine registered material. Why would a pharma company take risks like these? We can’t continue to develop drugs the same way as we have done before.

Generic Drugs 187

Generic Drugs Manufacturing Drugs Production 187

pharmaphorum

JULY 14, 2022

The legacy product now lies outside Bayer’s core areas of cardiology, oncology, haematology, ophthalmology, women’s health and radiopharmaceuticals, and the funds raised from the sale will support the “ongoing transformation of Bayer’s pharma business to focus on key areas of future medical innovation”, said the company.

Drugs 97

Drugs Sales Pharma Companies Cardiology 97

Pharmaceutical Technology

SEPTEMBER 2, 2022

In a recent report, GlobalData revealed that the US Food and Drug Administration (FDA) approved 122 new drug applications (NDAs) and biologic license applications (BLAs) in 2021. There are many reasons why a company might prefer to keep commercialisation activities inhouse. The rate of drug approvals could be on the rise.

Drugs 130

Drugs Pharma Companies Medicine Production 130

pharmaphorum

NOVEMBER 29, 2021

It was billed at the time as a key tool to accelerate the development of new and innovative vaccines to combat some of the world’s most prevalent diseases, from discovery to licensed product.

Vaccination 105

Vaccination Vaccine Manufacturing Pharma Companies 105

pharmaphorum

DECEMBER 22, 2021

Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not the one you would expect. Last year, it also signed a licensing deal with Dyno Therapeutics for its AAV capsid-based gene delivery technology focused on ocular diseases.

Gene Therapy 105

Gene Therapy Gene Licensing Licensing 105

pharmaphorum

JUNE 14, 2021

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. The earlier HTAs, researchers and pharma companies can start that engagement the better.

Drugs 105

Drugs Pharma Companies Licensing Licensing 105

pharmaphorum

MAY 20, 2022

In one of the first moves by a member of ATOM, Novartis has agreed to license rights to its tyrosine kinase inhibitor drug nilotinib – sold as Tasigna as a leukaemia treatment – to the UN-backed Medicines Patent Pool (MPP).

Drugs 111

Drugs Medicine Licensing Licensing 111

Pharmaceutical Technology

MARCH 31, 2023

On March 30, ViiV Healthcare and Medicines Patent Pool (MPP), announced sublicensing agreements with the pharma manufacturers Aurobindo , Cipla and Viatris to produce generic forms of the long-acting cabotegravir used as pre-exposure prophylaxis (PrEP) for HIV.

Medicine 130

Medicine Manufacturing Pharma Companies Licensing 130

pharmaphorum

OCTOBER 28, 2020

Identifying, recruiting, retaining and monitoring patients during this part of the cycle is estimated to cost pharma US$19 billion a year as companies seek to harvest patient experiences. Once a drug is licensed and launched, however, there is a deafening silence. 72% do not feel listened to by pharmaceutical companies.

Medicine 119

Medicine Pharma Companies Vaccination Vaccine 119

Fossil Remedies

SEPTEMBER 23, 2022

PCD Pharma Franchise is a popular business model. It is a business arrangement in which a pharma company offers the rights of marketing and distribution to its franchise partner. The pharma company thus expands its business and reaches new regions. Check the market reputation and image of the company.

Pharma Companies 52

Pharma Companies Production Licensing Licensing 52

pharmaphorum

AUGUST 4, 2020

Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to AstraZeneca. The company’s shares were valued as high as 95p on the London Stock Exchange following the announcement, the highest they had been since 2015.

Drugs 109

Drugs Clinical Trials Clinical Trials Pharma Companies 109

pharmaphorum

FEBRUARY 12, 2021

While Novartis is shoring up its position in generic antibiotics, the drugmaker decided the pursuit of new drugs that might help stem the rising tide in antimicrobial resistance (AMR) was too challenging, joining several other big pharma companies – including AstraZeneca, Roche, Bristol-Myers Squibb and Eli Lilly – in ducking out of the field.

Drugs 111

Drugs Sales Marketing Pharma Companies 111

pharmaphorum

JANUARY 7, 2022

If the last couple of days is an indication, 2022 is already shaping up to be the year of big-ticket alliances between big pharma companies and specialists in artificial intelligence-driven discovery. Shortly after Amgen unveiled its $1.9

Drugs 110

Drugs Pharma Companies Medicine Licensing 110

pharmaphorum

JUNE 4, 2021

The technology behind the drug was licensed from Weill Cornell Medicine and Johns Hopkins University in the US. ” The deal – financial terms of which were not disclosed – comes against a backdrop of increasing interest in radionuclide drugs among pharma companies.

Antibody 81

Antibody Licensing Licensing Protein 81

pharmaphorum

FEBRUARY 13, 2022

If all goes to plan, Merck has the option to obtain up to a five-year exclusive license to use of BioAI in a specific disease domain, which would result in an undisclosed payment to the Israeli startup. “If successful, this could lead to a much-needed transformation in drug development speed, safety and cost,” said Ciechanover.

Drugs 98

Drugs In-Vivo In-Vitro Pharma Companies 98

pharmaphorum

JANUARY 6, 2022

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead. Exelead was part of that success, helping to manufacture vaccine precursors for the Pfizer/BioNTech shot Comirnaty.

Vaccination 98

Vaccination Vaccine Manufacturing Life Science 98

pharmaphorum

OCTOBER 7, 2021

The factory will be able to supply up to 500 million doses of mRNA shots a year, and cover the full spectrum of manufacturing from drug substance production through to full/finish and packaging, according to the company. According to the latest WHO data, just 4.4%

Vaccination 98

Vaccination Vaccine Manufacturing Packaging 98

BioTech 365

OCTOBER 15, 2020

ISTANBUL–(BUSINESS WIRE)– Company name: Er-Kim Ilac Presentative: Cem Zorlular, CEO AnGes, Inc.,

Pharma Companies 40

Pharma Companies Licensing Licensing Gene 40

pharmaphorum

APRIL 21, 2022

One of the leading companies in the bid to bring a new class of alpha-synuclein targeting drugs to market for Parkinson’s disease – AbbVie – is ducking out of the challenge. Interest in the target has also prompted a flurry of licensing deals. AZ/Takeda are meanwhile running phase 2 trials of their MEDI 1342 antibody candidate.

Antibody 97

Antibody Protein Gene Therapy Pharma Companies 97

Camargo

SEPTEMBER 23, 2020

The panelists brought diverse perspectives on the future of orphan drug development, how their companies evaluate new potential products and partnering opportunities, and how they are working to address challenges like clinical study design and patient recruitment. Thomas Kassberg, Chief Business Officer, Ultragenyx.

Business Development 136

Business Development Drugs Development Production 136

pharmaphorum

SEPTEMBER 20, 2021

For the pharma industry, the pandemic’s changes were both abrupt and industry-altering, requiring companies to rapidly adapt their approaches to drug development and commercialisation. It also led to changes in how we manufacturer, market and ship medications.

Sales 98

Sales Marketing Pharma Companies Licensing 98

Creogenic Pharma

JULY 8, 2024

When you are attempting to find the best PCD Pharma Company, you will run into a lot of them in the country. How To Select Best PCD Pharma Franchise Company PCD PHARMA FRANCHISE BEST PCD PHARMA COMPANY In this article, we will walk you through some essential tips which will help you in selecting the best PCD Pharma Company.

Pharma Companies 52

Pharma Companies Production Licensing Licensing 52

pharmaphorum

APRIL 22, 2021

Although the company has no agreements in place to acquire any companies, or license in any drugs, Centessa is interested in exploring such opportunities if they arise. The money could also be used for further acquisitions as well as for working capital and general corporate purposes.

Licensing 64

Licensing Licensing Pharma Companies Drugs 64

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. But what steps can the smaller companies at the cutting edge take to make them acquisition-ready and maximise their value during this process?

Compliance 119

Compliance Regulation Manufacturing Licensing 119